Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study

for the AML-CG

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences